Physician profile
Joann Rapp
NPI 1275534554
$5,675.53
in general payments reported to CMS, 2019-2025
31 companies · $1,032 in 2025
The $1,032 reported for 2025 was more than what 90% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,041 · 2022: $541 · 2023: $1,124 · 2024: $1,937 · 2025: $1,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,093.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $744.21 | 2021-2025 | Pico 7, Renasys Go V2 Home, Pico |
| Si-Bone, INC. | $543.30 | 2021-2024 | |
| Bioventus LLC | $348.26 | 2021-2024 | Durolane, Durolane |
| Stryker Corporation | $326.35 | 2021-2025 | Inspace, System 9 Cd Nxt |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $299.02 | 2021-2025 | Rexulti |
| Zimvie INC. | $266.81 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $232.88 | 2024-2025 | Zilretta, Iovera |
| Neurelis, INC. | $228.09 | 2023-2024 | Valtoco |
| Zimmer Biomet Holdings, INC. | $225.00 | 2024-2025 | Accufill |
| Amgen INC. | $219.58 | 2021-2022 | |
| Medical Device Business Services, INC. | $211.48 | 2024-2025 | Stratafix |
| Gilead Sciences, INC. | $191.31 | 2021 | |
| Inari Medical, INC. | $183.80 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $143.00 | 2025 | Ostene |
| Next Science LLC | $140.80 | 2024 | Xperience, Surgx, Blastx |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $125.00 | 2023 | Erleada |
| Abbvie INC. | $124.76 | 2024 | |
| Heron Therapeutics, INC. | $122.11 | 2023 | Zynrelef |
| Pfizer INC. | $120.59 | 2025 | |
| Genzyme Corporation | $113.75 | 2024 | |
| Medtronic, INC. | $111.40 | 2021 | |
| Boston Scientific Corporation | $110.05 | 2024 | Watchman Flx |
| Bsn Medical INC | $99.36 | 2022 | |
| Edwards Lifesciences Corporation | $98.42 | 2023 | |
| Argenx US, INC. | $96.67 | 2022 | |
| Hologic Sales and Service, LLC | $86.72 | 2025 | Aptima |
| Mid-Atlantic Surgical Systems, LLC | $48.96 | 2024 | |
| Novo Nordisk INC | $37.89 | 2025 | Ozempic |
| Depuy Synthes Sales INC. | $28.04 | 2025 | Monovisc |
| Hydrofera LLC | $27.85 | 2024 | Hydrofera Blue |
| Ethicon US, LLC | $20.07 | 2025 | Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Rapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.